Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Compound Pepsin (marketed as Tongde Wei by Chengdu Tongde Pharmaceutical) is an oral combination formulation consisting of pepsin and thiamine (Vitamin B1). It is primarily used as a digestive aid to treat indigestion, loss of appetite, and dyspepsia, particularly in pediatric populations. Pepsin is a proteolytic enzyme that functions in the acidic environment of the stomach to catalyze the hydrolysis of dietary proteins into smaller peptides. Thiamine serves as an essential coenzyme (thiamine pyrophosphate) in carbohydrate metabolism and is vital for maintaining normal gastrointestinal motility and digestive function. The product is approved and widely used in China for symptomatic relief of digestive disorders.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on pepsin + thiamine.